BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4367563)

  • 1. Vincristine sulphate in the postoperative management of malignant supratentorial glioma.
    Afra D; Zoltán L; Gyenes G; Eckhardt S
    Ther Hung; 1974; 22(1):13-7. PubMed ID: 4367563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vincristine sulphate therapy in glioblastoma of the brain].
    Braham J; Sarova-Pinhas I; Goldhammer Y
    Harefuah; 1969 Oct; 77(7):303-5. PubMed ID: 4320097
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
    Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy of malignant gliomas.
    Skultety FM; Kumar PP; Good RR; Leibrock LG
    Nebr Med J; 1988 Jun; 73(6):166-8. PubMed ID: 2839782
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of cobalt-60-irradiation of brain tumors].
    Seyfeddinipur N; Gutjahr P; Kutzner J
    Strahlentherapie; 1975 Mar; 149(3):241-6. PubMed ID: 49957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.
    Hellman RM; Calogero JA; Kaplan BM
    J Neurooncol; 1990 Apr; 8(2):163-6. PubMed ID: 2162915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA; Wilson CB; Davis R; Wara WM; Pischer TL; Irwin L
    J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
    [No Abstract]   [Full Text] [Related]  

  • 9. [The 60Co radiotherapy of intracranial tumor (an analysis of 170 cases)].
    Zhang YL
    Zhonghua Fang She Xue Za Zhi; 1986 Oct; 20(5):302-5. PubMed ID: 3026754
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serial MRI and histological findings following intra-tumor local chemotherapy for malignant brain tumor].
    Shimura T; Nakazawa S; Takahashi H; Node Y; Tamai J; Kumazaki T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):209-18. PubMed ID: 8311491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indication and results of radiation therapy in the treatment of astrocytomas (author's transl)].
    Glanzmann C; Peters J; Horst W; Friede R
    Strahlentherapie; 1980 Jun; 156(6):382-7. PubMed ID: 6252666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of DTIC, ACNU, and vincristine combination chemotherapy for supratentorial malignant astrocytomas.
    Ikeda J; Aida T; Sawamura Y; Abe H; Kaneko S; Kashiwaba T; Kawamoto T; Mitsumori K; Saitoh H
    Neurol Med Chir (Tokyo); 1996 Aug; 36(8):555-8; discussion 558-9. PubMed ID: 8831197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
    Jeremić B; Grujicić D; Matović M
    Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of astrocytoma].
    Koga K; Nishikawa K; Watanabe K; Wakisaka S
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2546-50. PubMed ID: 2850329
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radiation therapy of malignant brain tumors: methodological aspects and personal experiences].
    Keim H
    Aktuelle Probl Chir Orthop; 1981; 18():46-57. PubMed ID: 6112898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.